Table 1. Summary of the pathological information of the patients a .
| Case | Age | Sex | Pathology | WHO grade | IDH 1 | Ki-67 (%) | MGMT | 1p/19q | Para- |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 49 | F | Anaplastic astrocytoma | III | Mutant | 8 | - | ||
| 2 | 61 | F | Glioblastoma | IV | WT | 20 | - | + | |
| 3 | 43 | M | Astrocytoma | II | Mutant | 5 | - | ||
| 4 | 51 | M | Anaplastic Oligodendroglioma | III | Mutant | 7 | - | + | |
| 5 | 26 | M | Diffuse astrocytoma | II | Mutant | 5 | - | ||
| 6 | 52 | F | Anaplastic astrocytoma | III | WT | 8 | - | ||
| 7 | 42 | F | Oligodendroglioma | II | WT | 10 | - | + | |
| 8 | 20 | M | Pilomyxiod astrocytoma | II | WT | 3 | - | ||
| 9 | 61 | M | Glioblastoma | IV | WT | 30 | - | ||
| 10 | 33 | F | Glioma | IV | WT | - | - | + | |
| 11 | 53 | M | Anaplastic astrocytoma | III | Mutant | 7 | - | + | |
| 12 | 64 | M | Gliosarcoma | IV | WT | 30 | - |
a
WHO grade: World health Organization; Ki-67(%): Ki-67 positive rate; para-: para-carcinoma tissue; 1p/19q: 1p/19q absence.